Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May;307(3):e220884.
doi: 10.1148/radiol.220884. Epub 2023 Apr 4.

Hepatocellular Carcinoma: It Is Time to Focus on Prognosis

Kathryn J Fowler  1 , Victoria Chernyak  1 , Maxime Ronot  1 , Valerie Vilgrain  1 , Azusa Kitao  1 , Jeong Min Lee  1 , Utaroh Motosugi  1 , Bin Song  1 , Hanyu Jiang  1 , Claude B Sirlin  1 , Mustafa R Bashir  1
Affiliations
Editorial

Hepatocellular Carcinoma: It Is Time to Focus on Prognosis

Kathryn J Fowler et al. Radiology. 2023 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: K.J.F. Member of Radiology editorial board; grants from GE, Siemens, Bayer; payment for lectures from Bayer Liver Forum; participation on founding board of Quantix Bio; ACR LI-RADS steering committee member. V.C. Consulting fees from Bayer. M.R. Payment for lectures from GE Healthcare, Ipsen, Canon-Toshiba, Alexion Pharmaceuticals, Guerbet, Sirtex. V.V. No relevant relationships. A.K. No relevant relationships. J.M.L. Grant from Samsung Medison, Siemens Healthineers, Philips Healthcare, GE Healthcare, Bayer, Guerbet, CMS, Canon Healthcare, Dongkuk Pharma; payment for lectures from Samsung Medison, GE Healthcare, Philips Healthcare, Starmed. U.M. No relevant relationships. B.S. No relevant relationships. H.J. Supported by the National Natural Science Foundation of China (81971571) and the Science and Technology Department of Sichuan Province (2021YFS0021). C.B.S. Research grants from ACR, Bayer, GE, Gilead, Pfizer, Philips, Siemens; Research grants from federal sources: NIH, DOD; Lab service agreements from Enanta, Gilead, ICON, Intercept, Nusirt, Shire, Synageva, Takeda; royalties or licenses from Medscape, Wolters Kluwer; consulting fees from Blade, Boehringer, Epigenomics, AMRA, BMS, Exact Sciences, IBM-Watson, Pfizer; honoraria from Educational Symposia; honoraria for visiting professor and /or grand rounds lectures from universities; member, Board of Directors of Society of Abdominal Radiology; stock options in Livivos; unpaid advisor for QuantixBio. M.R.B. Member of Radiology editorial board; grants from Carmot Therapeutics, Corcept Therapeutics, Diabetes and Endocrinology Consultants, Madrigal Pharmaceuticals, Metacrine, NGM Biopharmaceuticals, Polarean Imaging, ProSciento, Siemens Healthineers; consulting fees from ICON, MedPace.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. European Association For The Study Of The Liver; European Organization For Research And Treatment Of Cancer . EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma . J Hepatol 2012. ; 56 ( 4 ): 908 – 943 . [Published correction appears in J Hepatol 2012;56(6):1430.] - PubMed
    1. Yoon JH , Park JW , Lee JM . Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues . Korean J Radiol 2016. ; 17 ( 1 ): 7 – 24 . [Published correction appears in Korean J Radiol 2016;17(2):306.] - PMC - PubMed
    1. Heimbach JK , Kulik LM , Finn RS , et al. . AASLD guidelines for the treatment of hepatocellular carcinoma . Hepatology 2018. ; 67 ( 1 ): 358 – 380 . - PubMed
    1. Bolondi L , Burroughs A , Dufour JF , et al. . Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions . Semin Liver Dis 2012. ; 32 ( 4 ): 348 – 359 . - PubMed
    1. Lauwers GY , Terris B , Balis UJ , et al. . Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index . Am J Surg Pathol 2002. ; 26 ( 1 ): 25 – 34 . - PubMed